402 related articles for article (PubMed ID: 10605007)
1. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
[TBL] [Abstract][Full Text] [Related]
2. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
3. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G
J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351
[TBL] [Abstract][Full Text] [Related]
5. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
6. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
7. Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival.
Zhang M; Wang Q; Liu Y; Sun Y; Ding G; Fu Z; Min Z; Zhu Y; Cao X
J Mol Med (Berl); 2004 Apr; 82(4):240-9. PubMed ID: 15168681
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells.
Tada Y; O-Wang J; Takiguchi Y; Tatsumi K; Kuriyama T; Okada S; Tokuhisa T; Sakiyama S; Tagawa M
J Immunol; 2002 Sep; 169(5):2241-5. PubMed ID: 12193688
[TBL] [Abstract][Full Text] [Related]
9. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
10. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
[TBL] [Abstract][Full Text] [Related]
11. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
Deng C; Goluszko E; Christadoss P
J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
[TBL] [Abstract][Full Text] [Related]
12. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
14. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
[TBL] [Abstract][Full Text] [Related]
15. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
[TBL] [Abstract][Full Text] [Related]
16. Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation.
Whartenby KA; Straley EE; Kim H; Racke F; Tanavde V; Gorski KS; Cheng L; Pardoll DM; Civin CI
Blood; 2002 Nov; 100(9):3147-54. PubMed ID: 12384412
[TBL] [Abstract][Full Text] [Related]
17. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
19. Induction of CD4+ T cell apoptosis as a consequence of impaired cytoskeletal rearrangement in UVB-irradiated dendritic cells.
Wachter T; Averbeck M; Hara H; Tesmann JP; Simon JC; Termeer CC; Denfeld RW
J Immunol; 2003 Jul; 171(2):776-82. PubMed ID: 12847245
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells transduced with viral interleukin 10 or Fas ligand: no evidence for induction of allotolerance in vivo.
Buonocore S; Van Meirvenne S; Demoor FX; Paulart F; Thielemans K; Goldman M; Flamand V
Transplantation; 2002 Jan; 73(1 Suppl):S27-30. PubMed ID: 11810058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
